Clinical Trial Update: A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose [Phase 1]

View source ↗

Summary

A Phase 1 safety study of SB-681323 given as a single intravenous dose in healthy adult subjects has completed, with rheumatoid arthritis and inflammation liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SB-681323

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid, Inflammation | Phase 1 | Status: COMPLETED